ksm therapies ltd
ksm therapies ltd Company Information
Company Number
09013647
Next Accounts
Jan 2026
Directors
Shareholders
emily hampton-goodall
Group Structure
View All
Industry
Other education n.e.c.
+1Registered Address
unit 7 glebe farm business park, westerham road, keston, BR2 6AX
Website
kent-sportsmassage.co.ukksm therapies ltd Estimated Valuation
Pomanda estimates the enterprise value of KSM THERAPIES LTD at £31.6k based on a Turnover of £63k and 0.5x industry multiple (adjusted for size and gross margin).
ksm therapies ltd Estimated Valuation
Pomanda estimates the enterprise value of KSM THERAPIES LTD at £0 based on an EBITDA of £-5.6k and a 3.13x industry multiple (adjusted for size and gross margin).
ksm therapies ltd Estimated Valuation
Pomanda estimates the enterprise value of KSM THERAPIES LTD at £25.6k based on Net Assets of £10.9k and 2.34x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Ksm Therapies Ltd Overview
Ksm Therapies Ltd is a live company located in keston, BR2 6AX with a Companies House number of 09013647. It operates in the other education n.e.c. sector, SIC Code 85590. Founded in April 2014, it's largest shareholder is emily hampton-goodall with a 100% stake. Ksm Therapies Ltd is a established, micro sized company, Pomanda has estimated its turnover at £63k with rapid growth in recent years.
Upgrade for unlimited company reports & a free credit check
Ksm Therapies Ltd Health Check
Pomanda's financial health check has awarded Ksm Therapies Ltd a 3 rating. We use a traffic light system to show it exceeds the industry average on 3 measures and has 6 areas for improvement. Company Health Check FAQs
3 Strong
1 Regular
6 Weak
Size
annual sales of £63k, make it smaller than the average company (£573.2k)
- Ksm Therapies Ltd
£573.2k - Industry AVG
Growth
3 year (CAGR) sales growth of 35%, show it is growing at a faster rate (8.3%)
- Ksm Therapies Ltd
8.3% - Industry AVG
Production
with a gross margin of 26.9%, this company has a higher cost of product (48%)
- Ksm Therapies Ltd
48% - Industry AVG
Profitability
an operating margin of -8.9% make it less profitable than the average company (5.3%)
- Ksm Therapies Ltd
5.3% - Industry AVG
Employees
with 1 employees, this is below the industry average (14)
- Ksm Therapies Ltd
14 - Industry AVG
Pay Structure
on an average salary of £28.5k, the company has an equivalent pay structure (£28.5k)
- Ksm Therapies Ltd
£28.5k - Industry AVG
Efficiency
resulting in sales per employee of £63k, this is more efficient (£50.7k)
- Ksm Therapies Ltd
£50.7k - Industry AVG
Debtor Days
it gets paid by customers after 64 days, this is later than average (19 days)
- Ksm Therapies Ltd
19 days - Industry AVG
Creditor Days
its suppliers are paid after 15 days, this is quicker than average (20 days)
- Ksm Therapies Ltd
20 days - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- Ksm Therapies Ltd
- - Industry AVG
Cash Balance
There is insufficient data available for this Key Performance Indicator!
- - Ksm Therapies Ltd
- - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 15.1%, this is a lower level of debt than the average (24.3%)
15.1% - Ksm Therapies Ltd
24.3% - Industry AVG
KSM THERAPIES LTD financials
Ksm Therapies Ltd's latest turnover from April 2024 is estimated at £63 thousand and the company has net assets of £10.9 thousand. According to their latest financial statements, we estimate that Ksm Therapies Ltd has 1 employee and maintains cash reserves of 0 as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Apr 2024 | Apr 2023 | Apr 2022 | Apr 2021 | Apr 2020 | Apr 2019 | Apr 2018 | Apr 2017 | Apr 2016 | Apr 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 23,279 | 25,504 | ||||||||
| Other Income Or Grants | ||||||||||
| Cost Of Sales | ||||||||||
| Gross Profit | ||||||||||
| Admin Expenses | ||||||||||
| Operating Profit | ||||||||||
| Interest Payable | ||||||||||
| Interest Receivable | ||||||||||
| Pre-Tax Profit | 7,340 | 31,480 | ||||||||
| Tax | -1,395 | -5,980 | ||||||||
| Profit After Tax | 5,945 | 25,500 | ||||||||
| Dividends Paid | ||||||||||
| Retained Profit | 5,945 | 25,500 | ||||||||
| Employee Costs | ||||||||||
| Number Of Employees | ||||||||||
| EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Apr 2024 | Apr 2023 | Apr 2022 | Apr 2021 | Apr 2020 | Apr 2019 | Apr 2018 | Apr 2017 | Apr 2016 | Apr 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Tangible Assets | 1,758 | 2,343 | 3,125 | 4,167 | 5,556 | 6,576 | 6,968 | 802 | 1,070 | 600 |
| Intangible Assets | ||||||||||
| Investments & Other | ||||||||||
| Debtors (Due After 1 year) | ||||||||||
| Total Fixed Assets | 1,758 | 2,343 | 3,125 | 4,167 | 5,556 | 6,576 | 6,968 | 802 | 1,070 | 600 |
| Stock & work in progress | ||||||||||
| Trade Debtors | 11,114 | 16,837 | 12,404 | 30,159 | 13,649 | 18,104 | 14,622 | 13,823 | 3,631 | 983 |
| Group Debtors | ||||||||||
| Misc Debtors | ||||||||||
| Cash | 7,579 | 8,612 | ||||||||
| misc current assets | ||||||||||
| total current assets | 11,114 | 16,837 | 12,404 | 30,159 | 13,649 | 18,104 | 14,622 | 13,823 | 11,210 | 9,595 |
| total assets | 12,872 | 19,180 | 15,529 | 34,326 | 19,205 | 24,680 | 21,590 | 14,625 | 12,280 | 10,195 |
| Bank overdraft | ||||||||||
| Bank loan | ||||||||||
| Trade Creditors | 1,947 | 2,665 | 1,592 | 6,244 | 4,862 | 15,944 | 14,500 | 10,925 | 8,489 | 8,938 |
| Group/Directors Accounts | ||||||||||
| other short term finances | ||||||||||
| hp & lease commitments | ||||||||||
| other current liabilities | ||||||||||
| total current liabilities | 1,947 | 2,665 | 1,592 | 6,244 | 4,862 | 15,944 | 14,500 | 10,925 | 8,489 | 8,938 |
| loans | ||||||||||
| hp & lease commitments | ||||||||||
| Accruals and Deferred Income | 600 | |||||||||
| other liabilities | ||||||||||
| provisions | ||||||||||
| total long term liabilities | 600 | |||||||||
| total liabilities | 1,947 | 2,665 | 1,592 | 6,244 | 4,862 | 15,944 | 14,500 | 11,525 | 8,489 | 8,938 |
| net assets | 10,925 | 16,515 | 13,937 | 28,082 | 14,343 | 8,736 | 7,090 | 3,100 | 3,791 | 1,257 |
| total shareholders funds | 10,925 | 16,515 | 13,937 | 28,082 | 14,343 | 8,736 | 7,090 | 3,100 | 3,791 | 1,257 |
| Apr 2024 | Apr 2023 | Apr 2022 | Apr 2021 | Apr 2020 | Apr 2019 | Apr 2018 | Apr 2017 | Apr 2016 | Apr 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||
| Operating Profit | ||||||||||
| Depreciation | 1,041 | 1,388 | 268 | 200 | ||||||
| Amortisation | ||||||||||
| Tax | -1,395 | -5,980 | ||||||||
| Stock | ||||||||||
| Debtors | -5,723 | 4,433 | -17,755 | 16,510 | -4,455 | 3,482 | 799 | 10,192 | 2,648 | 983 |
| Creditors | -718 | 1,073 | -4,652 | 1,382 | -11,082 | 1,444 | 3,575 | 2,436 | -449 | 8,938 |
| Accruals and Deferred Income | -600 | 600 | ||||||||
| Deferred Taxes & Provisions | ||||||||||
| Cash flow from operations | ||||||||||
| Investing Activities | ||||||||||
| capital expenditure | ||||||||||
| Change in Investments | ||||||||||
| cash flow from investments | ||||||||||
| Financing Activities | ||||||||||
| Bank loans | ||||||||||
| Group/Directors Accounts | ||||||||||
| Other Short Term Loans | ||||||||||
| Long term loans | ||||||||||
| Hire Purchase and Lease Commitments | ||||||||||
| other long term liabilities | ||||||||||
| share issue | ||||||||||
| interest | ||||||||||
| cash flow from financing | -20,090 | -11,761 | ||||||||
| cash and cash equivalents | ||||||||||
| cash | -7,579 | -1,033 | 8,612 | |||||||
| overdraft | ||||||||||
| change in cash | -7,579 | -1,033 | 8,612 |
ksm therapies ltd Credit Report and Business Information
Ksm Therapies Ltd Competitor Analysis
Perform a competitor analysis for ksm therapies ltd by selecting its closest rivals, whether from the EDUCATION sector, other micro companies, companies in BR2 area or any other competitors across 12 key performance metrics.
ksm therapies ltd Ownership
KSM THERAPIES LTD group structure
Ksm Therapies Ltd has no subsidiary companies.
Ultimate parent company
KSM THERAPIES LTD
09013647
ksm therapies ltd directors
Ksm Therapies Ltd currently has 1 director, Mrs Emily Hampton-Goodall serving since Apr 2014.
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Mrs Emily Hampton-Goodall | England | 42 years | Apr 2014 | - | Director |
P&L
April 2024turnover
63k
-28%
operating profit
-5.6k
0%
gross margin
26.9%
+2.03%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
April 2024net assets
10.9k
-0.34%
total assets
12.9k
-0.33%
cash
0
0%
net assets
Total assets minus all liabilities
ksm therapies ltd company details
company number
09013647
Type
Private limited with Share Capital
industry
85590 - Other education n.e.c.
86900 - Other human health activities
incorporation date
April 2014
age
11
incorporated
UK
ultimate parent company
accounts
Micro-Entity Accounts
last accounts submitted
April 2024
previous names
N/A
accountant
-
auditor
-
address
unit 7 glebe farm business park, westerham road, keston, BR2 6AX
Bank
-
Legal Advisor
-
ksm therapies ltd Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to ksm therapies ltd.
ksm therapies ltd Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for KSM THERAPIES LTD. This can take several minutes, an email will notify you when this has completed.
ksm therapies ltd Companies House Filings - See Documents
| date | description | view/download |
|---|
